Longeveron Inc. (NASDAQ: LGVN)
$4.02
+0.5000 ( +14.21% ) 23.8M
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Market Data
Open
$4.02
Previous close
$3.52
Volume
23.8M
Market cap
$38.79M
Day range
$3.55 - $4.95
52 week range
$0.77 - $36.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 20, 2024 |
8-k | 8K-related | 16 | Mar 19, 2024 |
10-k/a | Quarterly Reports | 22 | Mar 11, 2024 |
8-k | 8K-related | 14 | Mar 07, 2024 |
10-k | Annual reports | 118 | Feb 27, 2024 |
8-k | 8K-related | 14 | Feb 22, 2024 |
def | Proxies and info statements | 3 | Feb 05, 2024 |
4 | Insider transactions | 1 | Feb 02, 2024 |
4 | Insider transactions | 1 | Jan 25, 2024 |
4 | Insider transactions | 1 | Jan 25, 2024 |